

Wed, Apr 29
|Online Seminar
Venture Valuation and Financial Models
Discover how top executives evaluate innovative companies and build financial models that drive investment decisions. This session will give you practical tools to turn scientific ideas into compelling, investable opportunities.
Details
Apr 29, 2026, 4:30 PM – 6:00 PM
Online Seminar
About the event
Session: Company Venture Valuation and Financial Models
This live online seminar is designed for executives and senior decision‑makers seeking a practical, high‑impact understanding of how innovative life sciences ventures are valued and how robust financial models are constructed. Participants will examine valuation frameworks, learn to assess market and technology risks, and translate scientific milestones into credible financial projections. The session combines expert insight with interactive discussion to deliver immediately applicable outcomes.
Guest Speaker

Dr. Mark Treherne
Chairperson of Talisman TX, former CEO of the Life Sciences Organisation of UK Trade & Investment, Curriculum Co-ordinator, BBI Cambridge, Cambridge UK.
Who should Attend
This seminar is relevant for professionals such as:
Life sciences executives and senior leaders
Corporate strategy, business development, and investment professionals
Venture capital, private equity, and finance professionals
R&D and commercial leaders involved in innovation strategy
Designed for leaders who require actionable financial insight without long‑form coursework. No advanced finance background is required - the session focuses on practical application.
What you will learn
Participants will gain practical knowledge in topics including:
Core valuation frameworks - Discounted Cash Flow (DCF), comparable company analysis, and venture capital methods
Structuring revenue forecasts, cost dynamics, and funding requirement models
Translating scientific and operational milestones into investor‑ready projections
Scenario planning to manage uncertainty in early‑stage ventures
By the end of the seminar participants will be able to evaluate investment opportunities, prepare compelling financial models, and make informed strategic choices for venture success.
What you will Receive
Live participation in the interactive seminar
Recording of the session - available after the event
Concise takeaway summary frameworks
Access to community resources and future sessions
Why Attend
Participants join more than a webinar - they benefit from a focused executive learning experience that delivers:
Strategic frameworks grounded in real life sciences markets
Interactive Q&A with a domain expert
Insights tailored to professional leadership and innovation challenges
Access to the recorded seminar for later review
Connection to the global BBI Cambridge professional network
Agenda
16:30 - Welcome and Introductions
16:45 - Key note - Company Venture Valuation and Financial Models
17:30 - Q&A with the audience
18:00 - Closing Remarks
Dr. Treherne brings extensive executive experience in life sciences strategy, investment and venture development, providing real‑world perspectives that bridge scientific innovation and investor expectations.
Register
BBIC Executive Seminar
Sale ends
Apr 28, 6:00 PM
A forum for senior leaders in life sciences to explore key topics - from venture valuation to innovation strategy - through practical insights, case studies, and actionable takeaways.
£125.00
+£3.13 ticket service fee
Total
£0.00